You are here

  • Home
  • Archive
  • Volume 10, Issue 5
  • Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinoma

 

Online download statistics by month:

Online download statistics by month: May 2022 to September 2025

AbstractFullPdf
May 2022521531200
Jun 2022387399186
Jul 2022251253125
Aug 202220721173
Sep 202218819080
Oct 202225925984
Nov 202218518582
Dec 202218318481
Jan 202311211245
Feb 202317017289
Mar 202312512575
Apr 2023989861
May 2023888943
Jun 2023848437
Jul 202311111266
Aug 2023818149
Sep 202310210255
Oct 202312212370
Nov 202312212268
Dec 2023141142115
Jan 202411411582
Feb 202410610676
Mar 2024115118108
Apr 2024129129101
May 202412913083
Jun 202412011977
Jul 202412012177
Aug 2024707165
Sep 2024757574
Oct 202411411471
Nov 202411712057
Dec 202414415183
Jan 202514815195
Feb 2025174176939
Mar 2025146149113
Apr 2025184185109
May 202514114292
Jun 2025878747
Jul 2025110
Sep 2025110
Total577258354033